foxo4-dri peptide senolytic animal model 2023 inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Molecular modelling of the FOXO4-TP53
Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect FOXO4 DRI FOXO4 p53 Peptide Peptagon FOXO4 DRI Peptide 10 mg Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



